Most Profitable NASDAQ Health Care Companies

Net Income
Net IncomeEfficiencyMarket RiskExp Return
1AZN AstraZeneca PLC ADR
6.9 B
(0.02)
 1.18 
(0.03)
2AMGN Amgen Inc
6.72 B
 0.09 
 1.23 
 0.11 
3GILD Gilead Sciences
5.61 B
 0.25 
 1.32 
 0.32 
4SNY Sanofi ADR
5.4 B
 0.23 
 1.23 
 0.29 
5GMAB Genmab AS
4.35 B
(0.05)
 1.78 
(0.09)
6ROIV Roivant Sciences
4.23 B
 0.10 
 1.81 
 0.18 
7REGN Regeneron Pharmaceuticals
3.95 B
 0.03 
 1.40 
 0.04 
8VRTX Vertex Pharmaceuticals
3.62 B
(0.03)
 1.24 
(0.04)
9ISRG Intuitive Surgical
1.82 B
 0.09 
 1.80 
 0.16 
10GEHC GE HealthCare Technologies
1.62 B
 0.18 
 1.42 
 0.26 
11BNTX BioNTech SE
1.19 B
 0.16 
 3.44 
 0.56 
12BIIB Biogen Inc
1.16 B
(0.14)
 1.60 
(0.22)
13RPRX Royalty Pharma Plc
1.13 B
 0.06 
 1.36 
 0.09 
14UTHR United Therapeutics
984.8 M
 0.10 
 1.99 
 0.19 
15IDXX IDEXX Laboratories
845.04 M
 0.04 
 1.59 
 0.07 
16ICLR ICON PLC
612.34 M
(0.04)
 1.91 
(0.07)
17INCY Incyte
597.6 M
 0.04 
 1.80 
 0.08 
18DXCM DexCom Inc
541.5 M
(0.10)
 5.70 
(0.58)
19ALKS Alkermes Plc
519.16 M
 0.12 
 2.02 
 0.24 
20HOLX Hologic
456 M
 0.17 
 1.10 
 0.19 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors. Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.